Novel triarylimidazoles

Details for Australian Patent Application No. 2004283846 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Voss, Edgar; Von Hirschheydt, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2004283846

PCT Pub. Number WO2005/040153

Priority 03023633.5 16.10.03 EP; 03026522.7 18.11.03 EP

Filing date 15 October 2004

Wipo publication date 6 May 2005

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040153 Priority application(s): WO2005/040153

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283850-Multispecific deimmunized CD3-binders

2004283845-Novel imidazole derivatives and their use as pharmaceutical agents